Get an alert when QUETHERA LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2027-04-02 (in 11mo)

Last made up 2026-03-19

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£5M

-52.9% vs 2024

Employees

0

Average over period

Profit before tax

-£7M

-382.2% vs 2024

Accounts

2-year trend · latest reflected 2025-03-31

Metric Trend 2024-03-312025-03-31
Turnover
Operating profit -£1,833,116-£7,336,966
Profit before tax -£1,457,673-£7,028,653
Net profit -£956,847-£5,271,489
Cash
Total assets less current liabilities £9,973,794£4,702,305
Net assets £9,973,794£4,702,305
Equity £9,973,794£4,702,305
Average employees 00
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-31
Return on capital employed -18.4%-156.0%
Gearing (liabilities / total assets) 3.4%18.9%
Current ratio 29.28x5.30x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Abridged
Yes — abridged accounts (limited disclosure)
Auditor
Ernst & Young
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The financial statements have been prepared on a going concern basis as a result of a letter of support from the group company, Astellas B.V.. After making due enquiries, including consideration of the letter of support received, the Directors of the Company confirm that they have a reasonable expectation that the Company has adequate resources to continue in operational existence for a period of twelve months from the date of approval of these financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 15 resigned

Name Role Appointed Born Nationality
FLOWERDEW, Lesley Ann Director 2026-02-01 Oct 1967 British
HIGASHITANI, Chieri, Ms. Director 2025-06-18 Jan 1980 American
MORTLOCK, Andrew Austen, Dr. Director 2025-06-18 Dec 1965 British
Show 15 resigned officers
Name Role Appointed Resigned
DOBREE, Anne Michelle, Dr Director 2018-02-28 2018-08-10
HALL, Stephen Andrew Director 2025-04-01 2025-12-10
HARDIMAN, Bradley William Director 2015-09-01 2017-06-12
HIRANO, Masaaki, Mr. Director 2018-08-10 2020-03-31
HOLBROOK, David Mark Anthony, Dr Director 2017-06-12 2018-02-28
JONSSON, Timothy Philip, Mr. Director 2018-08-10 2020-03-31
MARTIN, Keith Robert, Professor Director 2015-06-30 2018-08-10
MCDOUGALL, Alan, Dr Director 2022-04-01 2025-03-31
MORGAN, Piers John Director 2016-08-17 2018-08-10
PEARSON, Adam John Director 2020-04-01 2022-03-31
SAWAMOTO, Taiji Director 2022-04-01 2025-03-31
SEDDON, Natalie Louise Director 2020-04-01 2025-06-19
SEXTON, Peter Oliver Wharton Director 2015-09-01 2018-08-10
TOMURA, Yuichi, Mr. Director 2018-08-10 2022-03-31
WIDDOWSON, Peter Stuart Director 2013-03-19 2018-08-10

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Astellas Pharma Inc. Corporate entity Shares 75–100% 2018-08-10 Active
Mr Peter Stuart Widdowson Individual Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2018-08-10

Filing timeline

Last 20 of 84 total filings

Date Type Category Description
2026-03-30 CS01 confirmation-statement Confirmation statement with updates PDF
2026-02-10 SH01 capital Capital allotment shares PDF
2026-02-05 AP01 officers Appoint person director company with name date PDF
2026-01-28 TM01 officers Termination director company with name termination date PDF
2025-10-09 AA accounts Accounts with accounts type full
2025-06-23 AP01 officers Appoint person director company with name date PDF
2025-06-20 TM01 officers Termination director company with name termination date PDF
2025-06-20 AP01 officers Appoint person director company with name date PDF
2025-06-09 TM01 officers Termination director company with name termination date PDF
2025-04-11 AP01 officers Appoint person director company with name date PDF
2025-04-07 TM01 officers Termination director company with name termination date PDF
2025-03-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-12-30 AA accounts Accounts with accounts type full
2024-05-17 AAMD accounts Accounts amended with accounts type full
2024-05-17 AA accounts Accounts with accounts type full
2024-05-17 AAMD accounts Accounts amended with accounts type full
2024-05-17 AAMD accounts Accounts amended with accounts type full
2024-05-17 AAMD accounts Accounts amended with accounts type full
2024-05-01 RP04SH01 capital Second filing capital allotment shares PDF
2024-05-01 RP04SH01 capital Second filing capital allotment shares PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
9

last 12 months

Capital events
3

last 24 months

Officers appointed
3

last 12 months

Officers resigned
2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page